## CBRE: CBRE Group, Inc. - XLRE: Real Estate

### Executive Summary

VALUE thesis: PEG 0.82 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-2.4% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($155.06)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Camden Copper Square Apartments in Phoenix sell for $77M**
- Source: KTAR News 92.3 FM | 20251201T050000 | Neutral | Relevance: 72%
- The 332-unit Camden Copper Square Apartments in downtown Phoenix were sold for $77 million to ColRich, a San Diego-based real estate firm. The seller was Camden Property Trust, and the transaction was announced on November 20. The complex features various amenities, including two parking structures, swimming pools, coworking spaces, a fitness center, and a dog park.

**2. News | CoStar World News for Dec. 4**
- Source: CoStar | 20251203T232700 | Bullish | Relevance: 71%
- This article provides a global real estate news roundup for December 4, 2025, highlighting key developments in Japan's hotel market, JPMorgan Chase's plans for a new London headquarters, an LVMH-backed fund's investment in a French Riviera hotel, growth forecasts for German commercial investment, and an architectural project in Canada addressing loneliness. It also covers rising commercial real estate prices in the U.S., signaling a recovery trend.

**3. Prudential Financial Inc. Grows Stock Holdings in Elme Communities $ELME**
- Source: MarketBeat | 20251203T105614 | Somewhat-Bullish | Relevance: 65%
- Prudential Financial Inc. significantly increased its stake in Elme Communities by 27.2% to 279,382 shares, valued at approximately $4.44 million. Despite this increased institutional interest, Elme Communities reported mixed financial results, missing EPS estimates, and analysts maintain a cautious "Reduce" rating with a consensus price target of $18.50. The company faces profitability challenges, indicated by negative ROE and net margin, and its stock performance has been modest.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Barclays | $190 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Barclays | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 4 ($1.51M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 16.0% (-0.2%)
- Blackrock Inc.: 9.3% (-1.2%)
- State Street Corpora: 4.7% (+0.8%)
- Principal Financial : 3.2% (+9.3%)
- FMR, LLC: 2.8% (+89.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.82 indicates undervaluation relative to growth. Insider selling cluster ($1.5M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $49.0B |
| Beta | 1.34 |
| 52W Range | $108.45 - $171.00 |
| Short Interest | 1.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.82 |
| Forward P/E | 22.0 |
| Current P/E | 25.6 |
| YoY Growth | 16.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 4.9% to 2.5% (-2.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.5pp (needs >4.0% for momentum thesis). MRS_5 at 0.3% confirms short-term momentum alignment. AM_20 at 4.5% shows strong absolute momentum above own 20MA. Outperforming sector by 4.3pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.00), confirming momentum. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.53% (CS: 74) | Neutral |
| RSI_14 | 62.1 | Neutral |
| MACD Histogram | 1.00 | Bullish |
| vs SMA20 | 1.045x | Above |
| vs SMA50 | 1.041x | Above |
| vs SMA200 | 1.134x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $162.28
- **Stop Loss:** $155.06 (4.4% risk)
- **Target:** $176.72 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 65
- **Position Value:** $10,548.20
- **Portfolio %:** 10.55%
- **Risk Dollars:** $475.00
- **Risk Per Trade:** 0.47%
- **Modifiers:** L1 95% | L2 50% | Combined 0.47x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-12 (Est: $2.69)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.46 | $1.61 | +10.6% |
| 2025Q2 | $1.07 | $1.19 | +11.2% |
| 2025Q1 | $0.76 | $0.86 | +12.7% |
| 2024Q4 | $2.23 | $2.32 | +3.9% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*